Form 4 for DGX Quest Diagnostics
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0001022079-25-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-17 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $170.00 | -4,643 | 38.1K | -11% | -$789.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 4,643 | $170.00 | 38,117 | D | — | — |